Viewing Study NCT03506659


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-25 @ 4:33 PM
Study NCT ID: NCT03506659
Status: TERMINATED
Last Update Posted: 2020-02-28
First Post: 2018-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy électrochimique cutanée
Sponsor: Erasme University Hospital
Organization:

Study Overview

Official Title: Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy
Status: TERMINATED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Inclusion rate too low
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers
Detailed Description: Objective: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers

Background:

Sudoscan is a tool developed to evaluate and screen peripheral neuropathies in diabetes. His indication has been extended to other neuropathies such as post-chemotherapy, Fabry's disease, Parkinson's disease, familial amyloid polyneuropathy.

Main objective: Evaluation of the relevance of cutaneous electrochemical conductance in chronic peripheral neuropathies.

Methodology :

Recruitment of 2 groups of 2000 patients Group 1: Patients with chronic neuropathy, during clinic bread consultation Group 2: Patients to benefit from scheduled surgery seen during anesthesia consultation For both groups filling the central awareness inventory questionnaire

Analysis of the results after the recruitment has been completed.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: